ICD-10 Coding for Seropositive Rheumatoid Arthritis(L92.0U, M05.4, M05.79)
Learn about the ICD-10 coding for seropositive rheumatoid arthritis, including documentation requirements and common coding pitfalls.
Complete code families applicable to Seropositive Rheumatoid Arthritis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| M05.9 | Rheumatoid arthritis with rheumatoid factor, unspecified | Use when rheumatoid arthritis is confirmed with positive serology but specific joints or manifestations are not detailed. |
|
| M05.79 | Rheumatoid arthritis with rheumatoid factor, multiple sites | Use when multiple joints are affected and seropositivity is confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutSeropositive Rheumatoid Arthritis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Seropositive Rheumatoid Arthritis.
Failing to document serostatus
Impact
Clinical: May lead to inappropriate treatment choices., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims or reduced reimbursement.
Mitigation
Always include serology results in documentation, Use templates that prompt for serostatus
Using M06.9 for seropositive cases
Impact
Reimbursement: Potential underpayment due to incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data representation of patient conditions.
Mitigation
Use M05.9 or specific M05 codes when seropositivity is confirmed.
Use of unspecified codes
Impact
Using M06.9 when serostatus is known can trigger audits.
Mitigation
Always document and code for serostatus when available.